Vitamin K2 200 mcg + D3 with BioPerine by New Age — Ingredients, Evidence & Safety

🟢 100/100

This product looks safe

No ingredients exceed tolerable upper intake levels
50% of ingredients have research evidence

A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size

30 Servings

Botanical with Nutrients Product Type

50% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin D3

1000 IU (2500% DV)

✅ 1.7× RDA — within safe limits 📚 604 studies (Tier A: 16, B: 251)

RDA 0.015mg This product: 0.025mg UL 0.1mg

Vitamin K2

200 mcg (160% DV)

✅ 1.7× RDA — within safe limits 📚 273 studies (Tier A: 9, B: 175)

RDA 0.12mg This product: 0.2mg

Calcium

420 mg (30% DV)

Bioperine

10 mg

Other Ingredients

Kosher Gelatin non-GMO Vegetable Glycerin purified Water

Label Claims — Verification

❓ Nutrient

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement take two (2) capsules once a day. For best results take with a meal or as directed by your healthcare professional.

⚠️ Warnings & Precautions

Caution: Do not exceed recommended dose.

Always consult your healthcare professional before taking this or any dietary supplement, especially if you are under 18, if pregnant or nursing, or if you have a known medical condition.

Keep out of the reach of children.

Discontinue use if adverse reactions occur. Do not use if safety seal is damaged or missing.

🧪 Formulation Notes

100% Natural Ingredients

We represent Vitamin K2+D3 with BioPerine 3-in-1 Formula

Premium Quality

3-in-1 formula with BioPerine

MenaQ7 Vitamin K2 with MK-7

Naturally supports Heart health Bone health High absorption

Free from soy, gluten, milk, egg, wheat, GMOs, Peanuts and sugar. No artificial ingredients, fillers, chemicals, color additives, binders, or preservatives.

MenaQ7 sourced from Chickpea

Gluten Free Ingredients

Additional Information

New Age Best Seller

Store in a cool, dry place.

Want to know more about the product? We're here to help: support@newagenatural.com

Made in USA GMP Quality Good Manufacturing Practice Certification 3rd Party Certified Premium quality 100% natural

Product Details

DSLD Entry Date 2022-06-16

Product Type Botanical with Nutrients

Form Capsule

Brand New Age

DSLD ID 268708

Data Updated 2026-04-11

Research Evidence

332 Research Sources

59 Avg Quality Score

220 Meta Analysis

56 Systematic Review

30 Rct

16 Clinical Trial

3 Guideline

3 Regulatory Source

1 Narrative Review

1 Other

1 Openfda Safety

A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Meta Analysis The Cochrane database of systematic reviews 2014

PubMed DOI Cochrane

A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome

Meta Analysis The Cochrane database of systematic reviews 2017

PubMed DOI

A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI

A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair

Meta Analysis The Cochrane database of systematic reviews 2025

PubMed DOI

A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation

Meta Analysis The Cochrane database of systematic reviews 2018

PubMed DOI

A Antiplatelet agents and anticoagulants for hypertension

Systematic Review The Cochrane database of systematic reviews 2022

PubMed DOI

A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI

A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation